Identification of Novel Compounds Targeting the Liver X Receptor (LXR): In-silico Studies, Screening, Molecular Docking, and Chemico-pharmacokinetic Analysis DOI Open Access
Sarder Arifuzzaman,

Zubair Khalid Labu,

Md. Harun -Or- Rashid

и другие.

Biomedical & Pharmacology Journal, Год журнала: 2024, Номер 17(3), С. 1499 - 1522

Опубликована: Сен. 30, 2024

Studies have demonstrated the association between LXR activity dysregulation with many diseases, including atherosclerosis, diabetes and cancer. In recent years, several agonists surfaced, but none been approved for human use due to adverse effects or unforeseen reasons. this study, we first analysed mRNA protein expression of LXRs across tissues, network pathway analysis, reinterpreted their physiological function disease by utilizing multiple biological data repositories, RNA-seq atlas, DisGeNET, etc. Then, performed ligand-based virtual screening, chemico-pharmacokinetic docking simulation identify potential new compounds. Our findings mRNA, expression, enrichment analysis reveal diverse functions addressing possibility pharmacological manipulation small molecules would provide therapeutic strategies management. Evaluation properties directed selection LXR-623 AZ876 as promising candidates LXR-α LXR-β further in-silico investigation. Comprehensive screening ligands targeting based on chemical structures AZ876, identified ZINC000005399501 ZINC000021912941 highest binding affinity (−9.8 −10.7 kcal/mol) LXRα LXRβ, respectively. results also supported in along favorable features.

Язык: Английский

Establishing a robust triangulation framework to explore the relationship between hearing loss and Parkinson’s disease DOI Creative Commons
Hao Zhang,

Keying Chen,

Tongyu Gao

и другие.

npj Parkinson s Disease, Год журнала: 2025, Номер 11(1)

Опубликована: Янв. 3, 2025

The relationship between hearing loss (HL) and Parkinson's disease (PD) remains unclear. Using individual-level summary-level data from the UK Biobank largest genome-wide association studies, we examined this link through observational, Mendelian randomization genetic pleiotropy analyses. Among 158,229 participants, PD risk rose with HL severity especially in elder males, aids significantly reduced males. Although our results did not support a causal association, correlation analysis suggested localized overlap (17q21.31). We identified 1545 SNPs 63 genes pleiotropic effects on PD, including 79 novel across 6 loci, 3 showing strong co-localization. These loci were enriched key tissues like brain, heart, liver pancreas, linked to dihydrolipoyl dehydrogenase complex pathway, targeted by drugs such as Warfarin Phenprocoumon. Overall, study reveals basis, connecting PD.

Язык: Английский

Процитировано

0

Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet DOI Creative Commons
Manal M. Khowdiary, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

European Journal of Pharmacology, Год журнала: 2025, Номер unknown, С. 177419 - 177419

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Cell-penetrating proteins and peptides as a promising theragnostic agent for neurodegenerative disorder DOI Creative Commons
Bhaskaranand Pancholi,

Mayank Kumar Choudhary,

Manoj Kumar

и другие.

Journal of Drug Delivery Science and Technology, Год журнала: 2025, Номер unknown, С. 106816 - 106816

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Suicidal Ideation After Subthalamic Stimulation in Parkinson’s Disease: A Critical Concern DOI Creative Commons
Gideon S. Alex,

Oluwatobiloba Israel Popoola,

Inibehe Ime Okon

и другие.

Brain and Spine, Год журнала: 2025, Номер unknown, С. 104247 - 104247

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

0

Mitochondrial-based therapies for neurodegenerative diseases: a review of the current literature DOI Creative Commons

Al-Hassan Soliman Wadan,

Ahmed Shaaban, Mohamed El‐Sadek

и другие.

Naunyn-Schmiedeberg s Archives of Pharmacology, Год журнала: 2025, Номер unknown

Опубликована: Март 31, 2025

Abstract Neurodegenerative disorders present significant challenges to modern medicine because of their complex etiology, pathogenesis, and progressive nature, which complicate practical treatment approaches. Mitochondrial dysfunction is an important contributor the pathophysiology various neurodegenerative illnesses, including Alzheimer’s disease (AD), Parkinson’s (PD), amyotrophic lateral sclerosis (ALS). This review paper examines current literature highlighting multifaceted functions mitochondria, energy production, calcium signaling, apoptosis regulation, mitochondrial biogenesis, dynamics, axonal transport, endoplasmic reticulum–mitochondrial interactions, mitophagy, proteostasis, crucial involvement in neuronal health. The emphasizes increasing recognition as a critical factor progression disorders, marking shift from traditional symptom management innovative mitochondrial-based therapies. By discussing mechanisms, quality control (MQC) processes impact oxidative stress, this highlights need for novel therapeutic strategies restore function, protect connections integrity, slow progression. comprehensive aims provide insights into potential interventions that could transform landscape diseases, addressing symptoms underlying pathophysiological changes.

Язык: Английский

Процитировано

0

Neuroprotective Effect Of Thymus Vulgaris On Paraquat Induced Parkinson’s Disease DOI
Naheed Akhter,

Iqra Rafiq,

Amer Jamil

и другие.

Biochemical and Biophysical Research Communications, Год журнала: 2025, Номер unknown, С. 151740 - 151740

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Chenodeoxycholic Acid-Mediated neuroprotection via α-synuclein and BDNF Modulation in MPTP-Induced mouse model of Parkinson’s disease DOI

Mehwish Mehreen,

Megat Syahirul Amin Megat Ali, Hina Tariq

и другие.

Neuroscience, Год журнала: 2025, Номер unknown

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Glutamatergic dysfunction in neurodegenerative diseases focusing on Parkinson's disease: Role of glutamate modulators DOI Creative Commons
Najlaa H. Almohmadi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Brain Research Bulletin, Год журнала: 2025, Номер unknown, С. 111349 - 111349

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Blunted Melatonin Circadian Rhythm in Parkinson’s Disease: Express Bewilderment DOI
Areej Turkistani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Neurotoxicity Research, Год журнала: 2024, Номер 42(5)

Опубликована: Авг. 23, 2024

Язык: Английский

Процитировано

2

The neuroprotective effect of vitamin D in Parkinson's disease: association or causation DOI
Amin A. Hafiz

Nutritional Neuroscience, Год журнала: 2023, Номер 27(8), С. 870 - 886

Опубликована: Сен. 20, 2023

ABSTRACTParkinson's disease (PD) is a chronic neurodegenerative (NDD) due to the degeneration of dopaminergic neurons (DNs) in substantia nigra (SN). PD characterized by diverse motor symptoms such as rigidity, resting tremors, and bradykinesia, non-motor cognitive dysfunction sleep disturbances. Vitamin D (VD), VD receptor (VDR), metabolites are present brain play role maintaining development, differentiation, functions DNs. VDRs exert protective effects against neuropathology modulating functional capacity DNs neurotransmission SN. In virtue its anti-inflammatory antioxidant activities, could be effective prevention treatment PD. exerts neuroprotective effect reducing oxidative stress mitochondrial dysfunction, increasing autophagy brain-derived neurotrophic factor (BDNF). Low serum level connected with development dementia The VD-mediated augmenting interrelated safeguarding synaptic plasticity modulation neurotransmitter release. deficiency linked severity olfactory which precedes progression symptomatic However, precise remains unidentified, there conflict about whether can ameliorate or not.KEYWORDS: Parkinson's diseaseVitamin DVD receptorBDNFsubstantia nigraAutophagyOxidative stressdopaminergic AcknowledgementsNot applicable.Authors' contributionsAAH conceptualized manuscript, wrote, edited, reviewed main text approved final edition manuscript.Disclosure statementNo potential interest was reported author(s).Additional informationFundingThe author(s) no funding associated work featured this article.

Язык: Английский

Процитировано

6